Regeneron - PDFSEARCH.IO - Document Search Engine

Regeneron
Results: 62

#	Item
21	TRADE RELEASE NOT FOR WIRE DISTRIBUTION Regeneron Hires Brian Zambrowicz, Ph.D., as Vice President of Functional Genomics and Chief of VelociGene® Operations TARRYTOWN, N.Y. AprilRegeneron Pharmaceuticals, Inc Add to Reading List Source URL: www.regeneron.com Language: English - Date: 2015-04-07 14:06:33 Biotechnology Pharmacy Clinical research Regeneron Monoclonal antibodies George Yancopoulos Lexicon Pharmaceuticals Drug discovery Biopharmaceutical Pharmaceutical sciences Pharmacology Pharmaceutical industry
22	IBM Software Case Study Pharmaceuticals Regeneron Add to Reading List Source URL: public.dhe.ibm.com Language: English - Date: 2014-03-03 13:42:03 IBM Recruitment Monoclonal antibodies Business Computing Technology Regeneron Kenexa
23	July 30, 2014 Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission TARRYTOWN, N.Y. and PARIS, July 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Add to Reading List Source URL: files.shareholder.com Language: English Regeneron Pharmaceutical industry Food and Drug Administration Priority review voucher BioMarin Pharmaceutical Monoclonal antibodies Sanofi Pharmaceutical sciences Pharmacology Clinical research
24	Vitreo-Retinal Associates, P.C. Referral Form Diseases & Surgery of the Retina and Vitreous Jeffrey D. Zheutlin, M.D. Add to Reading List Source URL: www.vrapc.com Language: English - Date: 2015-02-23 15:29:17 Ranibizumab Macular degeneration Vascular endothelial growth factor Macular hole Genentech Regeneron Allergan Retina Epiretinal membrane Ophthalmology Vision Medicine
25	January 12, 2015 Regeneron and Sanofi Announce Praluent™ (alirocumab) Marketing Authorization Application has Been Accepted for Review by EMA TARRYTOWN, N.Y. and PARIS, Jan. 12, 2015 /PRNewswire/ -- Regeneron (NASDAQ: Add to Reading List Source URL: files.shareholder.com Language: English Regeneron Pharmaceutical industry European Medicines Agency Sanofi Monoclonal antibodies Pharmaceutical drug Food and Drug Administration Pharmaceutical sciences Pharmacology Clinical research
26	January 9, 2015 Regeneron and Sanofi Announce Positive Topline Results from First Phase 3 Trials Evaluating Monthly Dosing of Alirocumab in Patients with Hypercholesterolemia Primary efficacy endpoints met in two trials Add to Reading List Source URL: files.shareholder.com Language: English Health Regeneron Low-density lipoprotein Pharmaceutical industry Statin PCSK9 Clinical trial Pharmaceutical sciences Pharmacology Science
27	Regeneron Black and White Logo Add to Reading List Source URL: www.regeneron.com Language: English - Date: 2014-12-10 11:55:26 Monoclonal antibodies Biology Anakinra Adalimumab Infliximab Etanercept Omeprazole TNF inhibitor Norfloxacin Medicine Pharmacology Immunosuppressants
28	November 27, 2007 Astellas to Acquire Agensys, Inc. Japan, November 27, [removed]Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) today announced that its US subsidiary, Ast Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 20:28:39 Immunology Glycoproteins Biotechnology Monoclonal antibodies Regeneron Immunohistochemistry Biologic Antibody Phage display Biology Anatomy Immune system
29	ASTELLAS LICENSES REGENERON’S VELOCIMMUNE® TECHNOLOGY FOR DISCOVERING HUMAN MONOCLONAL ANTIBODIES Tokyo, Japan and Tarrytown, NY – (March 30, 2007) – Astellas Pharma Inc. (“Astellas”; Headquarters: Tokyo, Japa Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 21:30:47 Immune system Medicine Regeneron Monoclonal antibodies Astellas Pharma Biopharmaceutical Polyclonal antibodies Monoclonal antibody therapy George Yancopoulos Biotechnology Immunology Biology
30	FOR IMMEDIATE RELEASE Press Release Astellas to Pay $295 Million to Extend License of Regeneron’s VelocImmune® Antibody Technology through 2023 Tarrytown, NY and Tokyo, Japan – (July 28, 2010) –Regeneron Pharmaceu Add to Reading List Source URL: www.astellas.com Language: English - Date: 2010-07-28 00:50:35 Medicine Regeneron Immunology Pharmaceutical industry Astellas Pharma Monoclonal antibodies Pharmaceutical industry in India Rilonacept Biopharmaceutical Biotechnology Immunosuppressants Biology

UPDATE